Experience

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 17,250,000 shares of Class A common stock of Virtu Financial, Inc. for an…

Davis Polk advised the joint book-running managers and representatives of the underwriters in an SEC-registered offering by General Dynamics Corporation of $500 million aggregate…

Davis Polk acted as special product counsel to the representative of the several underwriters in connection with the SEC-registered offering of 5,750,000 shares (including 750,000…

Davis Polk, together with Slaughter and May, is advising Shire plc in connection with a recommended cash and stock offer for Shire’s entire share capital by Takeda Pharmaceutical Company…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Five9, Inc. of an aggregate principal amount of …

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $1.3 billion aggregate principal amount of 4.150% notes due 2048. Texas Instruments is a global…

Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 5,000,000 shares of common stock of Unity Biotechnology, Inc. Unity…

Davis Polk advised the joint global coordinators in the Hong Kong initial public offering of Ping An Healthcare and Technology Company Limited. The gross proceeds from the offering…

Davis Polk advised Charles Taylor plc on a placing of new shares representing approximately 9.75% of its current issued share capital which raised gross proceeds of approximately £17.6…

Davis Polk advised Sixsigma Networks México, S.A. de C.V. (“KIO Networks”) in connection with its Rule 144A/Regulation S offering of $300 million aggregate principal amount of its 7.500%…